# Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion

> **NCT00806910** · PHASE4 · WITHDRAWN · sponsor: **Albert Einstein Healthcare Network**

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Conivaptan
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00806910
- **Lead sponsor:** Albert Einstein Healthcare Network
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-10
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor support withdrawn
- **Last updated:** 2011-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806910, "Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00806910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*